HH Biotechnology Holdings CoOver The Counter Market:HHBT
- LAST PRICE0.0003
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0000 / 0.0003
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
HH Biotechnology Holdings Co | 4.2K | 0.0x | --- |
MVP Holdings Inc | 100.0 | 0.0x | --- |
Praetorian Property Inc | 160.0 | 0.0x | --- |
Investco Corp | 10.0 | 0.0x | --- |
Fangdd Network Group Ltd | 2.6M | 0.0x | --- |
Landmark Land Co Inc | 760.0 | 0.0x | --- |
Company Information
HH Biotechnology Holdings Company, formerly Great China International Holdings, Inc., is engaged in commercial and residential real estate investment, development, sales and/or management in the city of Shenyang, Liaoning Province, in the People’s Republic of China (PRC). The Company's business segments are Property for sale, and Rental income and Income of management fee of commercial buildings. The Company conducts all operations through its direct and indirect subsidiaries, which include Shenyang Maryland International Industry Company Limited and Silverstrand International Holdings Company Limited. It is focused primarily on real estate leasing, management and consulting activities in the city of Shenyang. The Company's leasing and management services are conducted primarily with respect to its real estate projects, which include President Building, Chenglong Garden and the Maryland Building. It also holds over 2,190 square meters of retail space in Qiyun New Village.
Contact Information
- Headquarters
- C Site 25-26F Presidential Building No. 69 Heping North StreetSHENYANG, LIA, China 110003
- Phone
- 242-281-3888
- Fax
- ---
Executives
- Chairman of the Board
- Frank Jiang
- Chief Executive Officer, Director
- Sheng Jiang
- Chief Financial Officer
- Lirong Wang
- Vice President - Operations
- Liang Zou
- Vice President of Marketing
- Sasaki Koji
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.2K |
|---|---|
Revenue (TTM) | $8.0M |
Shares Outstanding | 14.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $0.21 |
Book Value | $2.01 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 0.0 |
Price/Cash Flow (TTM) | 0.0x |
Operating Margin | 45.78% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
